FDA Unlikely To Approve Products That Hinge On Innovative Education Tools
This article was originally published in The Tan Sheet
Executive Summary
While FDA welcomes innovative ways to provide consumers with drug information beyond traditional definitions of labeling, sponsors cannot rely on these approaches when trying to secure an approval letter, an agency official said